Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/29/2003US20030101466 Method for screening for agents against cancer using an immunosuppression animal model
05/29/2003US20030100942 Hydrogel for the therapeutic treatment of aneurysms
05/29/2003US20030100889 Method of administration of a gene of interest to a vascular tissue
05/29/2003US20030100770 D-proline derivatives
05/29/2003US20030100768 Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100750 Process for solid supported synthesis of pyruvate-derived compounds
05/29/2003US20030100746 Methods and materials relating to fibulin-like polypeptides and polynucleotides
05/29/2003US20030100740 Protein for use in the treatment of blood disorders
05/29/2003US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid
05/29/2003US20030100574 Tricyclic 3,4-propinoperhydropurines; uses thereof for blocking neuronal transmission
05/29/2003US20030100570 Immunomodulation and effect on cell processes relating to serotonin family receptors
05/29/2003US20030100567 Tyrosine kinase inhibitors
05/29/2003US20030100561 Treatment of insulin resistance with growth hormone secretagogues
05/29/2003US20030100550 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
05/29/2003US20030100537 Calcium (3S) tetrahydro-3-furanyl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phos-phonooxy)propylcarbamate
05/29/2003US20030100531 8-30 nucleotides with 2' modified sugar moiety targeted to a nucleic acid molecule encoding human Interleukin-15, hybridizes and inhibits expression; anticancer agents and treating autoimmune diseases
05/29/2003US20030100530 Thyroid stimulating hormone sensitive cell that overexpresses pituitary tumor transforming gene in response to thyroid stimulating hormone
05/29/2003US20030100526 Operably linked mammalian muscle creatine kinase promoter, mammalian desmin promoter and enhancers thereof, and vertebrate troponin I IRE enhancer; gene therapy
05/29/2003US20030100525 Amino acid sequences; anticaner agents, monitoring, diagnosis
05/29/2003US20030100524 Inhibiting expression with 8-50 nucleobases that hydridizes to the encoding nucleic acid molecule; treating autoimmune diseases; antiinflammatory agents
05/29/2003US20030100522 Antisense modulation of ribonuclease L expression
05/29/2003US20030100521 For therapy of HIV infection
05/29/2003US20030100520 Immunizing mammal with inoculum containing a vehicle in which is dissolved or dispersed recombinant DNA molecule; maintaining immunized mammal for a time period for production of antibodies that bind to cholesteryl ester transfer protein
05/29/2003US20030100519 Using polyamide nucleic acid oligomers to engender a biological response
05/29/2003US20030100513 Methods and compositions for increasing the anaerobic working capacity in tissues
05/29/2003US20030100512 Gamma-secretase inhibitors
05/29/2003US20030100511 Contacting bone marrow or blood with glutamyl-S(benzyl)cysteinyl-R- phenyl glycine diethyl ester to stimulate hematopoiesis, protect hematopoietic cells from damage caused by radiation or chemotherapy
05/29/2003US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer
05/29/2003US20030100509 Injectable solution of an LHRH antagonist
05/29/2003US20030100508 Carbohydrate epitope mimic compounds and uses thereof
05/29/2003US20030100507 Administering to a mammal therapeutically effective amount of opiate analgesic and endothelin antagonist for therapy and prophylaxis of pain
05/29/2003US20030100506 Modified Vitamin K-dependent polypeptides
05/29/2003US20030100505 Concurrent therapy with insulin-like growth factor I (IGF-I) variant thereof and glycosaminoglycan, wherein concurrent therapy promotes a desired therapeutic response
05/29/2003US20030100504 Treatment and diagnosis of insulin-resistant states
05/29/2003US20030100503 Neurogenic compositions and methods
05/29/2003US20030100502 Promoting bone growth in a mammal by administrering LP85 polypeptide
05/29/2003US20030100501 For therapy of cystic fibrosis
05/29/2003US20030100500 Lowering circulating free fatty acid levels in an individual by administering to polypeptide and carrier
05/29/2003US20030100498 Administering human granulocyte-macrophage stimulating factor (GM-CSF) to induce a clinically significant increase in the patient's CD4+ T- lymphocyte count
05/29/2003US20030100497 For stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals
05/29/2003US20030100496 Compositions and methods for highly efficient transfection
05/29/2003US20030100495 Human NAC-1 protein
05/29/2003US20030100494 Containing growth hormone secretion promoting substance for prophylaxis and therapy of diseases involving degeneration or death of nerve cells
05/29/2003US20030100492 For induction of angiogenesis, bone fracture healing, enhancement of wound healing, promotion of tissue regeneration and therapy of ischemic heart diseases and peripheral vascular diseases
05/29/2003US20030100491 Novel proteins and nucleic acids encoding same
05/29/2003US20030100490 For therapy of arthritis, inflammatory dermatosis, inflammatory bowel disease, cancer, kidney fibrosis, inflammatory lung disease, obesity, lupus, cardiovascular disease and diabetes mellitus
05/29/2003US20030100488 Osteoprotegerin binding proteins
05/29/2003US20030100486 Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes
05/29/2003US20030100485 Human neurotrimin homolog
05/29/2003US20030100484 Cell in which a urotensin II receptor is formed is contacted with a chemical compound; activity or quantity of a gene, or its gene product, from the cell from is determined, comparing with gene product of control cell
05/29/2003US20030100483 As preservatives; in prophylaxis and therapy of viral or microbial infection in animals and plants, and in inactivating endotoxin
05/29/2003US20030100482 NMDA oxidizing agents for protecting neurons from injury
05/29/2003US20030100480 Methods and compositions for modulating sebaceous glands
05/29/2003US20030100114 Methods for regulating T cell subsets by modulating transcription factor activity
05/29/2003US20030100113 Plasmids for use in the transfer of nucleotide sequences into cells
05/29/2003US20030100108 Matrix for the production of tissue engineered ligaments, tendons and other tissue
05/29/2003US20030100096 Zcys5: a member of the cystatin superfamily
05/29/2003US20030100095 New human cathepsin
05/29/2003US20030100093 Human telomerase catalytic subunit: diagnostic and therapeutic methods
05/29/2003US20030100089 Protein for use in the treatment of angiogeneic, tumor, apoptotic, inflammatory, blood, viral, liver respiratory, arthritic and skin disorders
05/29/2003US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders
05/29/2003US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis
05/29/2003US20030100075 Human coagulation factor VII polypeptides
05/29/2003US20030100074 Nucleotide sequences coding polypeptide for use in treatment, diagnosis and prevention of bone disorders
05/29/2003US20030100072 Production of vascular endothelial cell growth factor and DNA encoding same
05/29/2003US20030100071 Polypeptide for use in the prevention and treatment of bacterial infections
05/29/2003US20030100070 Kunitz domain polypeptide Zkun11
05/29/2003US20030100069 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases
05/29/2003US20030100068 RANKL mimics and uses thereof
05/29/2003US20030100062 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases
05/29/2003US20030100058 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
05/29/2003US20030100057 Novel human G-protein coupled receptor, HGPRBMY14, related to the orphan GPCR, GPR73
05/29/2003US20030100055 Seleno-cysteine containing protein zsnk13
05/29/2003US20030100053 Nucleotide sequences coding polypeptide for use in the treatment of tumor disorders
05/29/2003US20030100051 97 human secreted proteins
05/29/2003US20030100047 Testis-specific receptor
05/29/2003US20030100046 Testis-specific receptor
05/29/2003US20030100034 Detection of modulators of cell activity; obtain cell, incubate with modulator, measure the concentration of target polypeptide, evaluate for cancer
05/29/2003US20030100033 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer in mammals
05/29/2003US20030100026 Stimulus-inducible protein kinase complex and methods of use therefor
05/29/2003US20030100016 Complement C3 precursor biopolymer markers predictive of Alzheimers disease
05/29/2003US20030100012 Plasma protease C1 biopolymer markers predictive of alzheimers disease
05/29/2003US20030099995 Protein for use in the diagnosis and treatment of cell proliferative and inflammatory disorders
05/29/2003US20030099994 Novel FDRG protein and nucleic acid molecules and uses therefor
05/29/2003US20030099991 Detection of nucleotide sequences associated pain and nervous system disorders; obtain sample, incubate with probe, detect signal, recover nucleic acid, incubate with primer, amplify, evaluate for disorder
05/29/2003US20030099990 TALL-1 receptor molecules and uses thereof
05/29/2003US20030099988 Novel Human tumor suppressor
05/29/2003US20030099980 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, and inflammamtory diseases
05/29/2003US20030099978 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
05/29/2003US20030099976 Androgen receptor complex-associated protein
05/29/2003US20030099971 Epidermal differentiation factor
05/29/2003US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer
05/29/2003US20030099959 Cooperative oligonucleotides
05/29/2003US20030099935 Core structure of GP41 from the HIV envelope glycoprotein
05/29/2003US20030099726 Medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution; for therapy
05/29/2003US20030099714 Co-lyophilizing one or more peptides or peptide analogues, which are able to adopt an amphipathic conformation and one or more lipids in a solvent system to form a peptide/lipid product, which can be rehydrated to form the complex
05/29/2003US20030099712 Therapeutic coating for an intravascular implant
05/29/2003US20030099709 Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
05/29/2003US20030099697 Amphoteric liposomes and their use
1 ... 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 ... 3163